期刊文献+

New Delhi Metallo-β-Lactamase-Mediated Carbapenem Resistance: Origin, Diagnosis, Treatment and Public Health Concern 被引量:5

New Delhi Metallo-β-Lactamase-Mediated Carbapenem Resistance: Origin, Diagnosis, Treatment and Public Health Concern
原文传递
导出
摘要 Objective: To review the origin, diagnosis, treatment and public health concern of New Delhi metallo-β-lactamase (NDM)-producing bacteria. Data Sources: We searched database for studies published in English. The database of PubMed from 2007 to 2015 was used to conduct a search using the keyword term "NDM and Acinetobacter or Enterobacteriaceae or Pseudomonas aeruginosa." Study Selection: We collected data including the relevant articles on international transmission, testing methods and treatment strategies of NDM-positive bacteria. Worldwide NDM cases were reviewed based on 22 case reports. Results: The first documented case of infection caused by bacteria producing NDM- 1 occurred in India, in 2008. Since then, 13 blaNDM variants have been reported. The rise of NDM is not only due to its high rate of genetic transfer among unrelated bacterial species, but also to human factors such as travel, sanitation and food production and preparation. With limited treatment options, scientists try to improve available therapies and create new ones. Conclusions: In order to slow down the spread of these NDM-positive bacteria, a series of measures must be implemented. The creation and transmission of blaNDM are potentially global health issues, which are not issues for one country or one medical community, but for global priorities in general and for individual wound care practitioners specifically. Objective: To review the origin, diagnosis, treatment and public health concern of New Delhi metallo-β-lactamase (NDM)-producing bacteria. Data Sources: We searched database for studies published in English. The database of PubMed from 2007 to 2015 was used to conduct a search using the keyword term "NDM and Acinetobacter or Enterobacteriaceae or Pseudomonas aeruginosa." Study Selection: We collected data including the relevant articles on international transmission, testing methods and treatment strategies of NDM-positive bacteria. Worldwide NDM cases were reviewed based on 22 case reports. Results: The first documented case of infection caused by bacteria producing NDM- 1 occurred in India, in 2008. Since then, 13 blaNDM variants have been reported. The rise of NDM is not only due to its high rate of genetic transfer among unrelated bacterial species, but also to human factors such as travel, sanitation and food production and preparation. With limited treatment options, scientists try to improve available therapies and create new ones. Conclusions: In order to slow down the spread of these NDM-positive bacteria, a series of measures must be implemented. The creation and transmission of blaNDM are potentially global health issues, which are not issues for one country or one medical community, but for global priorities in general and for individual wound care practitioners specifically.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2015年第14期1969-1976,共8页 中华医学杂志(英文版)
基金 Source of Support: This study was supported by grants from National Natural Science Foundation of China (No. 81101288 and 81172737). Conflict of Interest: None declared.
关键词 BACTERIAL Carbapenem Resistance Drug Resistance New Delhi Metallo-β-Lactamase Bacterial Carbapenem Resistance Drug Resistance New Delhi Metallo-β-Lactamase
  • 相关文献

参考文献94

  • 1Salcido RS. Super bugs: Survival of the fittest. Adv Skin Wound Care 2010;23:439.
  • 2Johnson AP, Woodford N. Global spread of antibiotic resistance: The example of New Delhi metallo-B-lactamase (NDM)-mediated carbapenem resistance. J Med Microbiol 2013;62(Pt 4):499-513.
  • 3Webster PC. Global action urged in response to new breed of drug-resistant bacteria. CMAJ 2010; 182:1602-3.
  • 4Rogers BA, Sidjabat HE, Silvey A, Anderson TL, Perera S, Li J, et al. Treatment options for New Delhi metallo-beta-lactamase-harboring Enterobacteriaceae. Microb Drug Resist 2013; 19:100-3.
  • 5EI-Herte RI, Kanj SS, Matar GM, Araj GF. The threat of carbapenem-resistant Enterobacteriaceae in Lebanon: An update on the regional and local epidemiology. J Infect Public Health 2012;5:233-43.
  • 6Charan J, Mulla S, Ryavanki S, Kantharia N. New Delhi Metallo-beta lactamase-1 containing Enterobacteriaceae: Origin, diagnosis, treatment and public health concern. Pan Aft" Med J 2012; 11:22.
  • 7Wailan AM, Paterson DL. The spread and acquisition of NDM-I: A multifactorial problem. Expert Rev Anti Ther 2014;12:91-115.
  • 8Darley E, Weeks J, Jones L, Daniels V, Wootton M, MacGowan A, et al. NDM-1 polymicrobial infections including Vibrio cholerae. Lancet 2012;380:1358.
  • 9Chen Y, Zhou Z, Jiang Y, Yu Y. Emergence of NDM-l-producing Acinetobacter baumannii in China. J Antimicrob Chemother 2011;66:1255-9.
  • 10Nordmann P, Poirel L, Walsh TR, Livermore DM. The emerging NDM carbapenemases. Trends Mierobiol 2011;19:588-95.

同被引文献12

引证文献5

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部